FDA NDC Directory · JSON-LD · Markdown

PERTZYE

NDC 59767-024 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Generic namepancrelipase
Labeler / ManufacturerDigestive Care, Inc.
Marketing categoryBiologic License Application · App BLA022175
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsPANCRELIPASE AMYLASE (90750 [USP'U]/1)
PANCRELIPASE LIPASE (24000 [USP'U]/1)
PANCRELIPASE PROTEASE (86250 [USP'U]/1)
Marketing started20170713
Package count4

External sources

Source: openFDA. Public-domain (CC0).